May 1, 2012, Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced that Andrew Bulpin, Head of Global Pharmaceutical Chemicals Solutions Sales at EMD Millipore has been appointed Head of the company’s Process Solutions Business Unit. He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts. Bulpin succeeds Jean-Paul Mangeolle, who is retiring from the company after 28 years of distinguished service.
“Andrew brings a wealth of leadership experience and an in-depth understanding of the life science markets,” noted Robert Yates, President of EMD Millipore. “With a continued focus on helping biopharmaceutical and pharmaceutical manufacturers advance their molecules to market, Andrew has an unprecedented opportunity to evolve the Process Solutions business.”
Bulpin joined Millipore Corporation in 2006 as Vice President for the Upstream Processing Business Unit and, in January 2012, assumed leadership of the Services and Solutions Business. Following the company’s acquisition by Merck, he was appointed to his current position.
Prior to EMD Millipore, Bulpin worked at Serologicals Corporation in a number of sales and marketing roles both in the U.S. and Europe. He holds a Ph.D. in organic chemistry from the Université de Caen, France; an MBA from the University of Strathclyde, Scotland; and a BSc from the University of Sussex, England. Bulpin also worked as a Post-Doctoral Research Fellow at the Australian National University, Australia.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA, Darmstadt, Germany, offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion.